SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-14-000677
Filing Date
2014-02-12
Accepted
2014-02-12 06:45:21
Documents
8
Period of Report
2014-02-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_021214.htm 8-K 28413
2 EXHIBIT 99.1 exh_991.htm EX-99.1 9194
3 EXHIBIT 99.2 exh_992.htm EX-99.2 3924
4 exh992_1.jpg GRAPHIC 171687
5 exh992_2.jpg GRAPHIC 211942
6 exh992_3.jpg GRAPHIC 192227
7 exh992_4.jpg GRAPHIC 156397
8 exh992_5.jpg GRAPHIC 195264
  Complete submission text file 0001171843-14-000677.txt   1321268
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33609 | Film No.: 14596577
SIC: 2834 Pharmaceutical Preparations